Literature DB >> 9489610

Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro.

R A Borman1, R Jewell, K Hillier.   

Abstract

1 We have investigated the effects of platelet-activating factor (PAF), an endogenous mediator of inflammation, on ion transport and prostaglandin synthesis in the human isolated colon. 2 Application of PAF to the serosal surface of human colonic mucosa induced a marked, concentration-dependent increase in ion transport. Mucosal application was without effect. 3 The secretory response to PAF was significantly inhibited by prior application of a specific PAF receptor antagonist WEB 2170, indicating that the response is dependent on PAF receptor activation. 4 The response to PAF was attenuated by prior application of indomethacin or piroxicam, implicating products of the cyclo-oxygenase pathway in the response. 5 The response to PAF was attenuated by the loop diuretic bumetanide, indicating an involvement of chloride ion secretion in the response. 6 Addition of PAF to the serosal surface induced a significant increase in serosal prostaglandin E2 (PGE2), but not 6-oxo-PGF1alpha release. There was no effect on mucosal application of PAF. 7 In summary, we have shown that PAF is a potent secretagogue in isolated preparations of human colon and that the response is dependent on a specific PAF receptor, cyclo-oxygenase products and bumetanide-sensitive chloride ion transport.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9489610      PMCID: PMC1565160          DOI: 10.1038/sj.bjp.0701602

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

1.  Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity.

Authors:  Jun Wu; Ake Nilsson; Bo A G Jönsson; Hanna Stenstad; William Agace; Yajun Cheng; Rui-Dong Duan
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

Review 2.  Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art.

Authors:  Barbara Vanhoecke; Emma Bateman; Bronwen Mayo; Eline Vanlancker; Andrea Stringer; Daniel Thorpe; Dorothy Keefe
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

3.  E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon.

Authors:  Hideki Sakai; Tomoyuki Suzuki; Miki Murota; Kiyoshi Oketani; Takaoki Uchiumi; Manabu Murakami; Noriaki Takeguchi
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

4.  Platelet-activating factor: a previously unrecognized mediator of fever.

Authors:  Andrei I Ivanov; Shreya Patel; Vladimir A Kulchitsky; Andrej A Romanovsky
Journal:  J Physiol       Date:  2003-10-17       Impact factor: 5.182

5.  Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent.

Authors:  Alip Borthakur; Sumit Bhattacharyya; Waddah A Alrefai; Joanne K Tobacman; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  Inflamm Bowel Dis       Date:  2010-04       Impact factor: 5.325

6.  Lactobacillus acidophilus alleviates platelet-activating factor-induced inflammatory responses in human intestinal epithelial cells.

Authors:  Alip Borthakur; Sumit Bhattacharyya; Anoop Kumar; Arivarasu Natarajan Anbazhagan; Joanne K Tobacman; Pradeep K Dudeja
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.